TGA Approval

ONBEVZI bevacizumab 400 mg/16mL concentrated injection for intravenous infusion vial (431838)

ARTG ID

431838

ARTG Name

ONBEVZI bevacizumab 400 mg/16mL concentrated injection for intravenous infusion vial

Sponsor

Samsung Bioepis AU Pty Ltd

ARTG Date

January 24, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Samsung Bioepis AU Pty Ltd

Ingredient Name

Bevacizumab

Empowering clinical research with data-driven insights and AI-powered tools.

ONBEVZI bevacizumab 400 mg/16mL concentrated injection for intravenous infusion vial (431838) - TGA 批准文号 | MedPath